Biogen Inc at TD Cowen Healthcare Conference Transcript
Good morning, and welcome to TD Cowen's 46 Annual Healthcare Conference. I'm Phil Nadeau, one of the Biotech analysts here at Cowen, and it's my pleasure to moderate a fireside chat with Chris Viehbacher, CEO of Biogen.
Questions & Answers
Chris, could you give us your vision for Biogen over the next five years? How is it going to create shareholder value?
So good morning, everybody. And Phil, I just want to thank you and Cowen for always holding the conference here in Boston. Given the temps outside it's too bad, we don't actually have a real fire for this fireside chat. So it's an exciting year for Biogen.
We have been on a journey to rebuild the company, expand its portfolio, its areas of focus. And just even in the last year, we've been adding meaningfully to our late-stage pipeline such that we now have 10 Phase III programs in the pipe. The
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
